Riskpilot← Back to searchSign inGet full accessDoctamed Oy
OYActiveY-tunnus 2977176-5Hussankatu 24-BComputer programming activities · NACE 6210Est. 2019— employees
Revenue 2025
EUR 0
EBITDA margin
—
+10% vs 2024
Equity ratio
95.3%
Financial strength
Net profit 2025
EUR 31K
+10% vs 2024
| Revenue | EUR 0 | — |
| EBITDA | EUR 39K | +10% |
| Net profit | EUR 31K | +10% |
| Total assets | EUR 155K | +16% |
| Equity | EUR 148K | +17% |
| Employees | — | — |
Legal name
Doctamed Oy
Y-tunnus number
2977176-5
Legal form
Osakeyhtiö
NACE code
6210 · Computer programming activities
Founded
5. helmikuuta 2019
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Ohjelmistojen suunnittelu ja valmistus, sekä kaikki muu laillinen liiketoiminta.
Address
Hussankatu 24-B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 63 | 33 | 41 | 0 | 0 |
| Staff expenses | — | −0 | −0 | −0 | −0 |
| EBITDA | 62 | 31 | 39 | 36 | 39 |
| Depreciation & amort. | — | — | −0 | −0 | −0 |
| EBIT | 62 | 31 | 39 | 36 | 39 |
| Net financials | — | −0 | −0 | 0 | 0 |
| Profit before tax | 62 | 31 | 39 | 36 | 39 |
| Tax | 12 | 6 | 8 | 7 | 8 |
| Net profit | 50 | 24 | 31 | 28 | 31 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 88 | 96 | 113 | 134 | 155 |
| Equity | 63 | 82 | 107 | 127 | 148 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 25 | 13 | 6 | 7 | 7 |
| Total debt | 25 | 13 | 6 | 7 | 7 |
EBITDA margin
3903800.0%
This company
15.8%
Market median
+24707495% vs market
20212025
Equity ratio
95.3%
This company
38.2%
Market median
+149% vs market
20212025
Return on equity
21.1%
This company
18.4%
Market median
+15% vs market
20212025
Net profit margin
3122700.0%
This company
8.1%
Market median
+38551752% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SK Deputy Member | Deputy Member | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2019 | |
| Board of Directors | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doctamed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Suvi Katri Mirjami Lehtinen | Deputy Member | 0 companies |
| Teemu Petteri Lankinen | Chairperson | 0 companies |
| Janne Kalle Markus Lehtinen | Board of Directors | 0 companies |